Population Council: HIV Infections trials

The registry lists 30 HIV Infections studies with Population Council as lead sponsor. 0 are open to participants now and 5 have results posted.

Early Phase 1 1Phase 1 21Phase 2 8Phase 3 4No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in WomenCompletedNCT02858037Phase 3Results posted
• Study of Dapivirine Vaginal Ring (VR) in AdolescentsCompletedNCT02028338Phase 2Results posted
• Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal WomenCompletedNCT02010593Phase 2Results posted
• Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in WomenCompletedNCT01617096Phase 3Results posted
• Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative WomenCompletedNCT01539226Not applicableResults posted
• Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008CompletedNCT05416021Phase 1
• Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal RingCompletedNCT02920827Phase 1
• Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating WomenCompletedNCT02808949Phase 1
• Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative AdultsCompletedNCT02346084Phase 1
• A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal RingCompletedNCT01755754Phase 1
• Functionality of Male Condoms With a Silicone Elastomer Vaginal RIngCompletedNCT01755741Phase 1
• Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring TrialsCompletedNCT01618058
• Assessing the Safety of Dapivirine Gel and Film FormulationsCompletedNCT01548560Phase 1
• Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal RingCompletedNCT01363037Phase 1
• A Safety and Efficacy Trial of Dapivirine Vaginal Ring in AfricaWithdrawnNCT01337583Phase 3
• A Safety and Efficacy Trial of Dapivirine Vaginal Ring in AfricaWithdrawnNCT01337570Phase 3
• A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in BelgiumWithdrawnNCT01242579Phase 1
• A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal RingCompletedNCT01144676Phase 1
• A Safety Study of Dapivirine Vaginal Ring in AfricaCompletedNCT01071174Phase 1/2
• An Expanded Safety Study of Dapivirine Gel 4789 in AfricaCompletedNCT00917904Phase 1/2
• An Expanded Safety Study of Dapivirine Gel 4759 in AfricaCompletedNCT00917891Phase 1/2
• Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)CompletedNCT00700284Phase 1
• A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal GelsCompletedNCT00613249Phase 1
• A Pharmacokinetic Study of Dapivirine Vaginal Rings in BelgiumCompletedNCT00469768Phase 1
• A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery MethodCompletedNCT00469170Early Phase 1
• Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in BelgiumCompletedNCT00332995Phase 1
• A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in BelgiumCompletedNCT00309205Phase 1/2
• A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South AfricaWithdrawnNCT00304668Phase 1/2
• A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide GelCompletedNCT00304642Phase 1
• A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide GelCompletedNCT00303576Phase 1/2